A high dose of Novo Nordisk’s obesity drug Wegovy led patients to lose substantial ... loss among people taking the currently approved 2.4-mg dose, and 3.9% among people taking placebo, Novo ...

A breakthrough in weight loss medication is on the horizon. While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more convenient ...

Sales of weight loss drug Wegovy more than doubled in the final three months of 2024 but its manufacturer has predicted growth will slow this year. Novo Nordisk's rise to become one of Europe's ...

This was significantly higher than the reduction achieved with standard dose Wegovy, 2.4mg, and the placebo, which resulted in losses of 17.5% and 2.4%, respectively. In addition, 33.2% of ...

In fact, Novo Nordisk recently reported positive results for one of its anti-obesity candidates that puts its current best-selling drug in this area, Wegovy, to shame. Let's look deeper into these ...

The company is spending billions to ramp up its Wegovy output as demand soars. "Emissions come with growth," said Katrine DiBona, corporate vice president of global public affairs and ...